| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| apixaban anti xa level interpretation | 0.53 | 0.9 | 9853 | 5 | 37 |
| apixaban | 1.72 | 0.9 | 8548 | 83 | 8 |
| anti | 1.01 | 1 | 8877 | 50 | 4 |
| xa | 0.83 | 1 | 3518 | 40 | 2 |
| level | 1.18 | 0.1 | 4461 | 30 | 5 |
| interpretation | 1.41 | 1 | 8395 | 97 | 14 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| apixaban anti xa level interpretation | 1.2 | 0.9 | 614 | 89 |
| anti xa level apixaban range | 1.8 | 0.7 | 989 | 97 |
| apixaban anti xa monitoring | 0.99 | 0.5 | 2653 | 68 |
| anti xa level interpretation | 0.89 | 0.7 | 9047 | 52 |
| apixaban factor xa inhibitor | 1.58 | 0.2 | 4799 | 16 |
| anti xa apixaban norme | 1.27 | 0.7 | 6546 | 28 |
| apixaban level blood test | 0.48 | 0.3 | 3020 | 93 |
| interpreting anti xa levels | 0.65 | 0.8 | 3708 | 90 |
| blood monitoring for apixaban | 0.52 | 0.9 | 4882 | 24 |
| apixaban and blood tests | 0.55 | 0.4 | 6866 | 55 |
| apixaban blood test monitoring | 1.55 | 0.5 | 4508 | 37 |
| apixaban monitoring blood tests | 1.91 | 0.7 | 5907 | 38 |
| apixaban indications for use | 0.25 | 0.5 | 2466 | 52 |
| apixaban information for patients | 1.13 | 1 | 9897 | 23 |
| low dose apixaban indication | 1.65 | 0.4 | 5916 | 73 |
| expected pharmacological action of apixaban | 1.53 | 1 | 9739 | 88 |
| apixaban lower dose criteria | 1.93 | 0.7 | 705 | 68 |
| apixaban in patients over 120kg | 0.67 | 0.5 | 3966 | 72 |
